Expectations: Understanding the Limitations of Point-of-Care Testing

Not all tests are created equal. In this free live webinar, you’ll uncover the benefits, science ,and shortfalls of rapid diagnostic testing. Hosted by Chief Product Officer, Eric Malis, we’ll cover everything from detection windows to cross-reactions and the importance of setting the right expectations. Don’t miss this opportunity to sharpen your knowledge and make better-informed testing decisions.

Beyond the Rapid Test: The Critical Role of Lab Confirmations in Toxicology

When a rapid toxicology test yields a positive result, the next step is crucial—confirmation through laboratory testing. While rapid tests provide quick insights, they can sometimes lead to false positives or incomplete data, impacting critical decisions in healthcare, workplace safety, and legal settings. This webinar will explore the importance of lab confirmations, the science behind definitive testing methods, and the potential consequences of relying solely on preliminary results.

2024 Drug Trends and Emerging Threats Report

Join us for an exclusive webinar uncovering the DEA’s 2024 Emerging Drug Threats and Trends Report. Gain crucial insights into the latest drug trends impacting communities across the United States. Learn about evolving substances, public health concerns, and how these issues shape enforcement and prevention strategies. Stay informed and prepared and don’t miss this opportunity to understand the critical challenges and solutions shaping our fight against drug abuse.

 

Sources:

DEA 2024 NDTA Report

DEA 2022 Emerging Threat Report

DEA 2024 STREET Report

U.S. Customs and Border Protection (CBP) Drug Seizures

 

Slide Deck:

2024 Emerging Drug Threats

Kratom Revisited: Latest Insights on Use, Effects, and Legal Status

Join our Chief Product Officer, Eric Malis, as he delves into the world of Kratom in this live recorded educational webinar. Gain key insights into its usage trends, potential effects, legal challenges, and advancements in drug testing. This is a must watch for anyone seeking clarity on this controversial substance.

Nitazenes: A Class of Synthetic Opioids More Potent Than Fentanyl

Join our Chief Product Officer, Eric Malis for another in-depth webinar on Nitazines, a potent and emerging class of synthetic opioids. We’ll explore current trends in Nitazine usage, the challenges in detecting and testing for these substances, and the latest screening methods, as well as, the significant threat they pose to public health. This session is crucial for healthcare professionals and policymakers to understand the growing impact of Nitazines and develop effective strategies to address the rise in use.

The State of Fentanyl and Opioids: 2024

In this live recorded webinar, we delve into the pressing topic of Fentanyl, other Opioids, usage, myths and the current state of the ongoing opioid crisis. Our Chief Product Officer, Eric Malis, will provide insights into these substances, including their impact on public health, trends in usage, regulatory measures, and innovative approaches to address the crisis. From the latest statistics to potential solutions, this webinar promises a comprehensive exploration of one of today’s most urgent public health challenges.